Lung Cancer News and Research

Latest Lung Cancer News and Research

Study of Nigerian breast cancer patients reveals prevalence of aggressive molecular features

A study comparing DNA and RNA data from Nigerian breast cancer patients to patients in a United States database found that certain aggressive molecular features were far more prevalent in tumors from Nigerian women than in black or white American women.

16 Oct 2018

Health effects of smoke-filled atmosphere

Every day, every human on the planet is exposed to one of the most toxic substances we know. However, it's largely invisible and most people don't know whether they need to worry. In new book Particles in the Air, Doug Brugge aims to raise awareness of serious consequences for public health.

16 Oct 2018

Modeling Non-Numerical Data in Systems Biology

An interview with Dr. Eshan Mitra, discussing the importance of computer models in biology and the development of a more accurate model of the RAF phosphorylation pathway.

15 Oct 2018

Lung cancer mortality rates are 28% lower in California

Early adoption of tobacco control efforts in California lead to fewer people ever smoking, reduced the amount used by those who do smoke and helped smokers quit at a younger age -- when their risk of developing lung cancer is lowest.

11 Oct 2018

Tobacco control must be highest priority in national cancer control plan, says report

The highest priority in a national cancer control plan must be expansion of tobacco control--the intervention with the largest potential health benefits--according to a new American Cancer Society report, the second in a series of articles that together inform priorities for a comprehensive cancer control plan.

11 Oct 2018

Phase 2 results on tazemetostat EZH2 inhibitor to be presented at ESMO 2018

Epizyme, Inc., a clinical-stage company developing novel epigenetic therapies, announced today that updated efficacy and safety data from the fully enrolled cohort of epithelioid sarcoma (ES) patients in its ongoing Phase 2 trial of tazemetostat will be presented in a poster discussion session at the European Society for Medical Oncology (ESMO) 2018 Congress to be held October 19-23 in Munich, Germany.

10 Oct 2018

Children with asthma have higher risk of obesity

Toddlers with asthma are more likely to become obese children, according to an international study led by USC scientists.

9 Oct 2018

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

Veracyte, Inc. announced the presentation of data demonstrating that the Envisia Genomic Classifier can help physicians more confidently diagnose interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF), without the need for surgery.

8 Oct 2018

New blood test may detect early-stage lung cancer when surgical intervention is not possible

Non-small-cell lung carcinoma is often fatal because most cases are not diagnosed until they are so advanced that surgical intervention is no longer possible. To improve outcomes researchers are developing a blood test to detect lung cancer earlier in the disease.

8 Oct 2018

Nanopore technology combined with DNA computing to catch early biomarkers for small cell lung cancer

Small Cell Lung Cancer is very aggressive, since the cancer cells not only quickly grow but also easily spread to entire body. Often SCLC can be diagnosed using several common tests unfortunately after spread of cancer cells, resulting in poor survival.

7 Oct 2018

Frequent surveillance imaging not associated with improved overall postoperative survival

Cancer treatment continues to improve for many types of cancer, leading to increased life expectancy for many survivors.

5 Oct 2018

Study shows adherence to annual lung cancer screening is not optimal

A study from the Thoracic Oncology Research Group (TORG), Division of Pulmonary and Critical Care, Medical University of South Carolina, aimed to examine the adherence to annual low-dose computed tomography (LDCT) screening after baseline LDCT within the Veteran Health Administration Lung Cancer Screening Demonstration Project (LCDSDP).

5 Oct 2018

New report provides overview of cancer risk among U.S. Hispanics/Latinos

The cancer burden in Puerto Rico, a U.S. territory with a 99% Hispanic population, is substantially different from that of Hispanics in the continental U.S., according to Cancer Statistics for Hispanics/Latinos, 2018.

4 Oct 2018

HalioDx announces availability of Brightplex, a high capacity IHC multiplex technology

HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple biomarkers to be analyzed on a single FFPE slide.

4 Oct 2018

Natural compound found in grapes may protect against cancer

Lung cancer is the deadliest form of cancer in the world, and 80% of death are related to smoking. In addition to tobacco control, effective chemoprevention strategies are therefore needed.

3 Oct 2018

Aggressive breast cancer hijacks normal protective physiological process to survive

A member of a protein family known for protecting our cells also protects cancer cells in aggressive, metastatic breast cancer, scientists report.

3 Oct 2018

Study highlights need for measures to improve annual lung cancer screening adherence

A study from the Thoracic Oncology Research Group, Division of Pulmonary Critical Care, Medical University of South Carolina aimed to examine the adherence to annual low-dose computed tomography screening after baselines LDCT within the Veteran Health Administration Lung Cancer Screening Demonstration Project.

1 Oct 2018

Researchers design new combination therapy for reducing NSCLC cell growth

Lung cancer is the leading cause of cancer death among men and women. About 85 percent of lung cancers are non-small cell lung cancer. For a handful of these patients, therapies that target specific genetic mutations are effective.

29 Sep 2018

Cancer risk due to lifestyle and environmental factors can be prevented

Almost four in every 10 new cases of cancer in Germany are attributable to lifestyle and environmental factors. These include primarily smoking, low physical activity, overweight, and infections.

28 Sep 2018

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved VIZIMPRO [vih-ZIM-pro] (dacomitinib), a kinase inhibitor for the first-line treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.

28 Sep 2018

Lung Cancer News and Research

Latest Lung Cancer News and Research

Study of Nigerian breast cancer patients reveals prevalence of aggressive molecular features

Health effects of smoke-filled atmosphere

Modeling Non-Numerical Data in Systems Biology

Lung cancer mortality rates are 28% lower in California

Tobacco control must be highest priority in national cancer control plan, says report

Phase 2 results on tazemetostat EZH2 inhibitor to be presented at ESMO 2018

Children with asthma have higher risk of obesity

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

New blood test may detect early-stage lung cancer when surgical intervention is not possible

Nanopore technology combined with DNA computing to catch early biomarkers for small cell lung cancer

Frequent surveillance imaging not associated with improved overall postoperative survival

Study shows adherence to annual lung cancer screening is not optimal

New report provides overview of cancer risk among U.S. Hispanics/Latinos

HalioDx announces availability of Brightplex, a high capacity IHC multiplex technology

Natural compound found in grapes may protect against cancer

Aggressive breast cancer hijacks normal protective physiological process to survive

Study highlights need for measures to improve annual lung cancer screening adherence

Researchers design new combination therapy for reducing NSCLC cell growth

Cancer risk due to lifestyle and environmental factors can be prevented

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in